These data demonstrate that ovarian cancer cells express several Drp1/DNM1L splice variants, with a high abundance of Drp1(-/17) expression, and suggest that splicing of exon 16 and retention of exon 17 might be of significance to ovarian cancer. Here, DNM1L is linked to ovarian carcinoma.